π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The purpose of this study is to determine which doses of Urelumab and Nivol...
Status
Terminated
Location
Stanford University School Of Medicine
Start Date
2014-09-29
Trial ID
NCT02253992
The purpose of this study is to assess the safety and tolerability of BMS-6...
Status
Completed
Location
Local Institution
Start Date
2015-11-06
Trial ID
NCT02534506
This study evaluates the post cystectomy CD8+ tumor response of patients re...
Status
Active Not Recruiting
Location
UCLA Institute of Urologic Oncology
Start Date
2017-05-16
Trial ID
NCT02845323
Treatments Being Tested
This is a Phase I/II, ascending, multi-dose study of BMS-663513, an agonist...
Status
Terminated
Location
City Of Hope National Medical Center
Start Date
2005-12
Trial ID
NCT00309023
Treatments Being Tested
Open label, phase I-II study to evaluate the safety and activity of intratu...
Status
Unknown
Location
Clinica Universidad de Navarra
Start Date
2019-01-30
Trial ID
NCT03792724
Treatments Being Tested
The purpose of the study is to determine the safety, tolerability and maxim...
Status
Completed
Location
Stanford University
Start Date
2014-04
Trial ID
NCT02110082
This phase I trial studies the safety and best dose of anti-LAG-3 (anti-LAG...
Status
Completed
Location
UAB Comprehensive Cancer Center
Start Date
2016-08-24
Trial ID
NCT02658981
The purpose of this study is to determine the maximum tolerated dose and as...
Status
Terminated
Location
The Cancer Institute Of New Jersey
Start Date
2008-01
Trial ID
NCT00461110
Treatments Being Tested